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Optical Coherence Tomography 
Findings Facilitate the Diagnosis of 
Autosomal Recessive Spastic Ataxia 
of Charlevoix-Saguenay
Dear Editor,
In patients with slowly progressing ataxia, molecular ge-
netic investigation can be considered for the identification 
of underlying cause. Before considering genetic tests, com-
prehensive neurological and ophthalmological investiga-
tions should be done first. In this report, we present a rare 
case of a patient who was diagnosed with autosomal reces-
sive spastic ataxia of Charlevoix-Saguenay (ARSACS) 
based on thickened retinal nerve fiber layers (RNFLs) and 
whole genome sequencing.
A 53-year-old male was referred from the department of 
neurology for diplopia of 6 months’ duration. His past 
medical history was significant for the gait disturbance 
since age of 10. The patient had experienced progressive 
gait difficulty with frequent falls and was unable to walk 
independently at the age of 17. At the age of 40 years, dys-
arthria and dysphagia developed, and brain magnetic reso-
nance imaging (MRI) showed cerebellar atrophy. His 
younger sister had similar symptoms, which indicated an 
autosomal recessive trait. Best-corrected visual acuity was 
20 / 25 in the right eye and 20 / 40 in the left eye. Slit lamp 
examination revealed pseudophakia in the right eye and 
cortical opacity in the left eye. The patient had a full range 
of eye movement, but defective pursuit movements were 
noted. Extraocular motility examination showed 25 prism 
diopters exotropia at near with Krimsky methods. Dilated 
fundus examination showed diffuse peripapillary retinal 
nerve fiber striations in both eyes. Optical coherence to-
mography (OCT) revealed thickening of RNFLs in both 
eyes (Fig. 1A-1D). Neurophysiologic studies were consis-
tent with predominantly demyelinating sensori-motor 
polyneuropathy. Brain MRI showed cerebellar atrophy and 
pontine linear hypointense striations (Fig. 1). Genetic tests 
for Friedreich’s ataxia (FRDA) and for the most common 
repeat expansion (spinocerebellar ataxia [SCA] 1, 2, 3, 6, 7, 
8, 17, and dentatorubro-pallidoluysian atrophy) were all 
negative. Alpha-fetoprotein and vitamin E level (7.4 mg/L, 
normal 5.5–17.0) were normal, and echocardiography was 
also normal. Whole genome sequencing was performed, 
and it revealed two compound heterozygous variants 
c.7272C>A:p.(Cys2424*), c.11319_11321del:p.(Arg3774del) 
in the SACS gene (NM_014363.4). These two variants were 
absent in gnomAD and predicted to be deleterious (CADD 
score 33 and 19.39, respectively). The former variant was 
previously reported [1], and it is considered as pathogenic. 
The latter in-frame deletion is a deletion of highly con-
served arginine, deposited in ClinVar (VCV000853474) 
and considered as likely pathogenic (PM1, PM2, PM4, PP3, 
and PP4). Due to absence of his parents, we could not de-
termine the phase of two variants.
ARSACS was f irst described in the families of the 
Charlevoix and Saguenay regions of Quebec, Canada [2]. 
Unsteady walking is the first symptom of ARSACS, fol-
lowed by slowly progressive muscle spasticity, problems 
with coordination and reduced sensation and weakness in 
the extremities [2]. Affected individuals also had slurred 
speech, saccadic pursuit, and nystagmus. Although the 
typical age of onset is early childhood (3.4 ± 1.6 years), 
wide variability of age at onset (infancy to >40 years) has 
also been described [3]. The causative gene was found to 
be a mutation in the SACS gene, which encodes for the 
sacsin. Its function is thought to be essential for neurofila-
ment arrangement and mitochondrial dynamics. Previous 
literature reported that only one patient had diplopia 
among 17 patients with ARSACS [4]. The cerebellar atro-
phy may be responsible for the diplopia. The average peri-
papillary RNFL thickness of 119 µm showed the greatest 
differentiation between ARSACS and other causes [4].
Given the diagnostic complexity in hereditary ataxia, ac-
curate phenotyping is essential to make a correct diagnosis. 
Ataxia-telangiectasia, FRDA, and SCA are differential diag-
noses to be considered. The diagnosis of ataxia-telangiecta-
sia was deferred because conjunctival telangiectasia was ab-
sent in this patient. OCT findings revealed RNFL thinning 
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in FRDA [5]. In addition, substantial portion of patients with 
FRDA developed cardiomyopathy, which is inconsistent 
with our case [5]. The SCA 7 typically presented with cone 
dystrophy with ataxia, and this disorder is inherited as dom-
inant trait. If thickening of RNFL is observed in patients 
with progressive ataxia, ARSACS could be the cause.
Although ARSACS has no specific treatment, prompt 
and appropriate diagnosis bears important prognostic im-
plications. In patients with hereditary ataxia, pontine linear 
hypointensities on MRI and RNFL thickening on OCT 
may provide important clues for diagnosis. Comprehensive 
ophthalmological assessment in conjunction with pertinent 
medical history may guide to differentiate the cause of he-
reditary ataxia, and this makes us to avoid unnecessary 
trinucleotide repeat expansion tests for SCAs.
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Fig. 1. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. (A) Sagittal T1 image shows cerebellar vermis atrophy. (B) Axial T1 
sequence shows bilateral pontine linear hypointense lesion (arrows). (C) Fundus photograph reveals retinal striations (arrowhead) nasal to 
the fovea (right eye was shown) (D) Optical coherence tomography showing elevated fovea pit and thickened retinal nerve fiber layer (ar-
rowheads) nasal to the fovea, corresponding to the retinal striations. Informed consent for publication of the clinical images was obtained 
from the patient.
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